ENTITY

Perspective Therapeutics (CATX US)

1
Analysis
Health CareUnited States
Perspective Therapeutics, Inc. operates as a biotech company. The Company develops cesium-131 brachytherapy seeds and has a proprietary technology that utilizes the isotope lead-212 to deliver powerful alpha radiation specifically to cancer cells via specialized targeting peptides. Perspective Therapeutics serves customers worldwide.
more
Company Event11 Aug 2026 04:00 • Upcoming
Add To Calendar
Company Event20 May 2026 02:05 • Latest
Company Event14 May 2026 05:20
Company Event12 May 2026 04:00 • Upcoming
Add To Calendar
Company Event16 Apr 2026 20:00 • Upcoming
Add To Calendar
x